ID   MPIP2_HUMAN             Reviewed;         580 AA.
AC   P30305; D3DVY1; D3DVY2; D3DVY3; D3DVY4; O43551; Q13971; Q5JX77;
AC   Q6RSS1; Q9BRA6;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   27-MAY-2002, sequence version 2.
DT   15-MAR-2017, entry version 182.
DE   RecName: Full=M-phase inducer phosphatase 2;
DE            EC=3.1.3.48;
DE   AltName: Full=Dual specificity phosphatase Cdc25B;
GN   Name=CDC25B; Synonyms=CDC25HU2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1836978; DOI=10.1016/0092-8674(91)90294-9;
RA   Galaktionov K.I., Beach D.;
RT   "Specific activation of cdc25 tyrosine phosphatases by B-type cyclins:
RT   evidence for multiple roles of mitotic cyclins.";
RL   Cell 67:1181-1194(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1662986;
RA   Nagata A., Igarashi M., Jinno S., Suto K., Okayama H.;
RT   "An additional homolog of the fission yeast cdc25+ gene occurs in
RT   humans and is highly expressed in some cancer cells.";
RL   New Biol. 3:959-968(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 2 AND 3).
RX   PubMed=9188863; DOI=10.1038/sj.onc.1201063;
RA   Baldin V., Cans C., Superti-Furga G., Docommun B.;
RT   "Alternative splicing of the human CDC25B tyrosine phosphatase.
RT   Possible implications for growth control?";
RL   Oncogene 14:2485-2495(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LYS-548.
RG   NIEHS SNPs program;
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 56-352 (ISOFORMS 2 AND 3).
RA   McCormack A.K., DeSouza C.C.P.C., Tonks I.D., Clark J.M.,
RA   Forrest A.R.R., Hayward N.K., Ellem K.A.O., Gabrielli B.G.;
RT   "Alternative splicing of cdc25B.";
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   PHOSPHORYLATION AT SER-323 AND SER-375, AND INTERACTION WITH MAPK14
RP   AND 14-3-3 PROTEINS.
RX   PubMed=11333986; DOI=10.1038/35075107;
RA   Bulavin D.V., Higashimoto Y., Popoff I.J., Gaarde W.A., Basrur V.,
RA   Potapova O., Appella E., Fornace A.J. Jr.;
RT   "Initiation of a G2/M checkpoint after ultraviolet radiation requires
RT   p38 kinase.";
RL   Nature 411:102-107(2001).
RN   [10]
RP   PHOSPHORYLATION AT SER-323.
RX   PubMed=12400006; DOI=10.1038/sj.onc.1205870;
RA   Davezac N., Baldin V., Blot J., Ducommun B., Tassan J.P.;
RT   "Human pEg3 kinase associates with and phosphorylates CDC25B
RT   phosphatase: a potential role for pEg3 in cell cycle regulation.";
RL   Oncogene 21:7630-7641(2002).
RN   [11]
RP   PHOSPHORYLATION AT SER-375.
RC   TISSUE=Testis;
RX   PubMed=15150265; DOI=10.1074/jbc.M404728200;
RA   Lu R., Niida H., Nakanishi M.;
RT   "Human SAD1 kinase is involved in UV-induced DNA damage checkpoint
RT   function.";
RL   J. Biol. Chem. 279:31164-31170(2004).
RN   [12]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-353 BY AURKA.
RX   PubMed=15128871; DOI=10.1242/jcs.01108;
RA   Dutertre S., Cazales M., Quaranta M., Froment C., Trabut V.,
RA   Dozier C., Mirey G., Bouche J.P., Theis-Febvre N., Schmitt E.,
RA   Monsarrat B., Prigent C., Ducommun B.;
RT   "Phosphorylation of CDC25B by Aurora-A at the centrosome contributes
RT   to the G2-M transition.";
RL   J. Cell Sci. 117:2523-2531(2004).
RN   [13]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION BY CHEK1.
RX   PubMed=15311285; DOI=10.1038/ncb1165;
RA   Kraemer A., Mailand N., Lukas C., Syljuaesen R.G., Wilkinson C.J.,
RA   Nigg E.A., Bartek J., Lukas J.;
RT   "Centrosome-associated Chk1 prevents premature activation of cyclin-B-
RT   Cdk1 kinase.";
RL   Nat. Cell Biol. 6:884-891(2004).
RN   [14]
RP   PHOSPHORYLATION AT SER-169, AND SUBCELLULAR LOCATION.
RX   PubMed=15908796; DOI=10.4161/cc.4.6.1716;
RA   Mirey G., Chartrain I., Froment C., Quaranta M., Bouche J.P.,
RA   Monsarrat B., Tassan J.P., Ducommun B.;
RT   "CDC25B phosphorylated by pEg3 localizes to the centrosome and the
RT   spindle poles at mitosis.";
RL   Cell Cycle 4:806-811(2005).
RN   [15]
RP   PHOSPHORYLATION AT SER-323 BY MAPKAPK2.
RX   PubMed=15629715; DOI=10.1016/j.molcel.2004.11.021;
RA   Manke I.A., Nguyen A., Lim D., Stewart M.Q., Elia A.E., Yaffe M.B.;
RT   "MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the
RT   G2/M transition and S phase progression in response to UV
RT   irradiation.";
RL   Mol. Cell 17:37-48(2005).
RN   [16]
RP   FUNCTION, AND PHOSPHORYLATION.
RX   PubMed=17332740; DOI=10.1038/sj.emboj.7601637;
RA   Schmidt A., Durgan J., Magalhaes A., Hall A.;
RT   "Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit
RT   from cytokinesis.";
RL   EMBO J. 26:1624-1636(2007).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249; SER-323; SER-353;
RP   SER-375; SER-470 AND SER-563, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.91 ANGSTROMS) OF 370-580.
RX   PubMed=10543950; DOI=10.1006/jmbi.1999.3168;
RA   Reynolds R.A., Yem A.W., Wolfe C.L., Deibel M.R. Jr., Chidester C.G.,
RA   Watenpaugh K.D.;
RT   "Crystal structure of the catalytic subunit of Cdc25B required for
RT   G2/M phase transition of the cell cycle.";
RL   J. Mol. Biol. 293:559-568(1999).
CC   -!- FUNCTION: Tyrosine protein phosphatase which functions as a
CC       dosage-dependent inducer of mitotic progression. Required for G2/M
CC       phases of the cell cycle progression and abscission during
CC       cytokinesis in a ECT2-dependent manner. Directly dephosphorylates
CC       CDK1 and stimulates its kinase activity. The three isoforms seem
CC       to have a different level of activity.
CC       {ECO:0000269|PubMed:17332740}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate.
CC   -!- ENZYME REGULATION: Stimulated by B-type cyclins.
CC   -!- SUBUNIT: Interacts with MAPK14 and 14-3-3 proteins.
CC       {ECO:0000269|PubMed:11333986}.
CC   -!- INTERACTION:
CC       P31946:YWHAB; NbExp=5; IntAct=EBI-1051746, EBI-359815;
CC       Q04917:YWHAH; NbExp=4; IntAct=EBI-1051746, EBI-306940;
CC       P63104:YWHAZ; NbExp=5; IntAct=EBI-1051746, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:15128871,
CC       ECO:0000269|PubMed:15311285, ECO:0000269|PubMed:15908796}.
CC       Cytoplasm, cytoskeleton, spindle pole
CC       {ECO:0000269|PubMed:15908796}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=3; Synonyms=CDC25B3;
CC         IsoId=P30305-1; Sequence=Displayed;
CC       Name=1; Synonyms=CDC25B1;
CC         IsoId=P30305-2; Sequence=VSP_000861;
CC       Name=2; Synonyms=CDC25B2;
CC         IsoId=P30305-3; Sequence=VSP_000862;
CC       Name=4;
CC         IsoId=P30305-4; Sequence=VSP_000861, VSP_012587;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylated by BRSK1 in vitro. Phosphorylated by CHEK1,
CC       which inhibits the activity of this protein. Phosphorylation at
CC       Ser-353 by AURKA might locally participate in the control of the
CC       onset of mitosis. Phosphorylation by MELK at Ser-169 promotes
CC       localization to the centrosome and the spindle poles during
CC       mitosis. Phosphorylation at Ser-323 and Ser-375 by MAPK14 is
CC       required for binding to 14-3-3 proteins.
CC       {ECO:0000269|PubMed:11333986, ECO:0000269|PubMed:12400006,
CC       ECO:0000269|PubMed:15128871, ECO:0000269|PubMed:15150265,
CC       ECO:0000269|PubMed:15311285, ECO:0000269|PubMed:15629715,
CC       ECO:0000269|PubMed:15908796, ECO:0000269|PubMed:17332740}.
CC   -!- SIMILARITY: Belongs to the MPI phosphatase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdc25b/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M81934; AAA58416.1; -; mRNA.
DR   EMBL; S78187; AAB21139.1; -; mRNA.
DR   EMBL; X96436; CAA65303.1; -; Genomic_DNA.
DR   EMBL; Z68092; CAA92108.1; -; mRNA.
DR   EMBL; AY494082; AAR26469.1; -; Genomic_DNA.
DR   EMBL; AL109804; CAC17548.1; -; Genomic_DNA.
DR   EMBL; AL109804; CAC17549.1; -; Genomic_DNA.
DR   EMBL; AL109804; CAI18847.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10491.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10492.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10493.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10494.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10496.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10497.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10498.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10499.1; -; Genomic_DNA.
DR   EMBL; BC006395; AAH06395.1; -; mRNA.
DR   EMBL; BC009953; AAH09953.1; -; mRNA.
DR   EMBL; BC051711; AAH51711.1; -; mRNA.
DR   EMBL; AF036233; AAB94622.1; -; Genomic_DNA.
DR   EMBL; AF036233; AAB94624.1; -; Genomic_DNA.
DR   CCDS; CCDS13065.1; -. [P30305-2]
DR   CCDS; CCDS13066.1; -. [P30305-3]
DR   CCDS; CCDS13067.1; -. [P30305-1]
DR   PIR; B41648; B41648.
DR   RefSeq; NP_001274448.1; NM_001287519.1.
DR   RefSeq; NP_001274453.1; NM_001287524.1.
DR   RefSeq; NP_004349.1; NM_004358.4. [P30305-2]
DR   RefSeq; NP_068658.1; NM_021872.3. [P30305-3]
DR   RefSeq; NP_068659.1; NM_021873.3. [P30305-1]
DR   UniGene; Hs.153752; -.
DR   PDB; 1CWR; X-ray; 2.10 A; A=370-580.
DR   PDB; 1CWS; X-ray; 2.00 A; A=370-580.
DR   PDB; 1CWT; X-ray; 2.30 A; A=388-565.
DR   PDB; 1QB0; X-ray; 1.91 A; A=370-580.
DR   PDB; 1YM9; X-ray; 2.00 A; A=391-564.
DR   PDB; 1YMD; X-ray; 1.70 A; A=391-564.
DR   PDB; 1YMK; X-ray; 1.70 A; A=391-564.
DR   PDB; 1YML; X-ray; 1.70 A; A=391-564.
DR   PDB; 1YS0; X-ray; 2.00 A; A=391-564.
DR   PDB; 2A2K; X-ray; 1.52 A; A=391-564.
DR   PDB; 2IFD; X-ray; 2.00 A; A=391-564.
DR   PDB; 2IFV; X-ray; 1.60 A; A=391-564.
DR   PDB; 2UZQ; X-ray; 2.38 A; A/B/C/D/E/F=391-580.
DR   PDB; 3FQT; X-ray; 1.80 A; C=38-46.
DR   PDB; 3FQU; X-ray; 1.80 A; C=38-46.
DR   PDB; 4WH7; X-ray; 1.62 A; A=386-565.
DR   PDB; 4WH9; X-ray; 1.50 A; A=386-565.
DR   PDBsum; 1CWR; -.
DR   PDBsum; 1CWS; -.
DR   PDBsum; 1CWT; -.
DR   PDBsum; 1QB0; -.
DR   PDBsum; 1YM9; -.
DR   PDBsum; 1YMD; -.
DR   PDBsum; 1YMK; -.
DR   PDBsum; 1YML; -.
DR   PDBsum; 1YS0; -.
DR   PDBsum; 2A2K; -.
DR   PDBsum; 2IFD; -.
DR   PDBsum; 2IFV; -.
DR   PDBsum; 2UZQ; -.
DR   PDBsum; 3FQT; -.
DR   PDBsum; 3FQU; -.
DR   PDBsum; 4WH7; -.
DR   PDBsum; 4WH9; -.
DR   ProteinModelPortal; P30305; -.
DR   SMR; P30305; -.
DR   BioGrid; 107429; 34.
DR   DIP; DIP-323N; -.
DR   IntAct; P30305; 16.
DR   MINT; MINT-124404; -.
DR   STRING; 9606.ENSP00000245960; -.
DR   BindingDB; P30305; -.
DR   ChEMBL; CHEMBL4804; -.
DR   DrugBank; DB03661; Cysteinesulfonic Acid.
DR   DEPOD; P30305; -.
DR   iPTMnet; P30305; -.
DR   PhosphoSitePlus; P30305; -.
DR   DMDM; 21264471; -.
DR   EPD; P30305; -.
DR   MaxQB; P30305; -.
DR   PaxDb; P30305; -.
DR   PeptideAtlas; P30305; -.
DR   PRIDE; P30305; -.
DR   DNASU; 994; -.
DR   Ensembl; ENST00000245960; ENSP00000245960; ENSG00000101224. [P30305-1]
DR   Ensembl; ENST00000340833; ENSP00000339170; ENSG00000101224. [P30305-3]
DR   Ensembl; ENST00000439880; ENSP00000405972; ENSG00000101224. [P30305-2]
DR   GeneID; 994; -.
DR   KEGG; hsa:994; -.
DR   UCSC; uc002wjn.5; human. [P30305-1]
DR   CTD; 994; -.
DR   DisGeNET; 994; -.
DR   GeneCards; CDC25B; -.
DR   HGNC; HGNC:1726; CDC25B.
DR   HPA; HPA038892; -.
DR   HPA; HPA038893; -.
DR   MIM; 116949; gene.
DR   neXtProt; NX_P30305; -.
DR   OpenTargets; ENSG00000101224; -.
DR   PharmGKB; PA26260; -.
DR   eggNOG; KOG3772; Eukaryota.
DR   eggNOG; COG5105; LUCA.
DR   GeneTree; ENSGT00390000018747; -.
DR   HOVERGEN; HBG052501; -.
DR   InParanoid; P30305; -.
DR   KO; K05866; -.
DR   OMA; ITPCSLD; -.
DR   OrthoDB; EOG091G0H0D; -.
DR   PhylomeDB; P30305; -.
DR   TreeFam; TF101056; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-157881; Cyclin B2 mediated events.
DR   Reactome; R-HSA-69273; Cyclin A/B1 associated events during G2/M transition.
DR   Reactome; R-HSA-69656; Cyclin A:Cdk2-associated events at S phase entry.
DR   Reactome; R-HSA-8862803; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models.
DR   SIGNOR; P30305; -.
DR   ChiTaRS; CDC25B; human.
DR   EvolutionaryTrace; P30305; -.
DR   GeneWiki; CDC25B; -.
DR   GenomeRNAi; 994; -.
DR   PRO; PR:P30305; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000101224; -.
DR   CleanEx; HS_CDC25B; -.
DR   ExpressionAtlas; P30305; baseline and differential.
DR   Genevisible; P30305; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; TAS:Reactome.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; TAS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007144; P:female meiosis I; IEA:Ensembl.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; TAS:UniProtKB.
DR   GO; GO:0007067; P:mitotic nuclear division; TAS:ProtInc.
DR   GO; GO:0001556; P:oocyte maturation; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   Gene3D; 3.40.250.10; -; 1.
DR   InterPro; IPR000751; MPI_Phosphatase.
DR   InterPro; IPR001763; Rhodanese-like_dom.
DR   Pfam; PF06617; M-inducer_phosp; 1.
DR   Pfam; PF00581; Rhodanese; 1.
DR   PRINTS; PR00716; MPIPHPHTASE.
DR   SMART; SM00450; RHOD; 1.
DR   SUPFAM; SSF52821; SSF52821; 1.
DR   PROSITE; PS50206; RHODANESE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Cell division;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Hydrolase; Mitosis;
KW   Phosphoprotein; Polymorphism; Protein phosphatase; Reference proteome.
FT   CHAIN         1    580       M-phase inducer phosphatase 2.
FT                                /FTId=PRO_0000198644.
FT   DOMAIN      431    538       Rhodanese. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00173}.
FT   ACT_SITE    487    487
FT   MOD_RES      42     42       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P48966}.
FT   MOD_RES     169    169       Phosphoserine; by MELK.
FT                                {ECO:0000269|PubMed:15908796}.
FT   MOD_RES     249    249       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     323    323       Phosphoserine; by MELK and MAPK14.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11333986,
FT                                ECO:0000269|PubMed:12400006,
FT                                ECO:0000269|PubMed:15629715}.
FT   MOD_RES     353    353       Phosphoserine; by AURKA.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:15128871}.
FT   MOD_RES     375    375       Phosphoserine; by BRSK1 and MAPK14.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11333986,
FT                                ECO:0000269|PubMed:15150265}.
FT   MOD_RES     470    470       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     563    563       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      68     81       Missing (in isoform 1 and isoform 4).
FT                                {ECO:0000303|PubMed:1662986,
FT                                ECO:0000303|PubMed:1836978}.
FT                                /FTId=VSP_000861.
FT   VAR_SEQ     154    194       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9188863}.
FT                                /FTId=VSP_000862.
FT   VAR_SEQ     194    194       N -> NVRFWKAGVGALREEEGACWGGSLACEDPPLPSWLQ
FT                                (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_012587.
FT   VARIANT     548    548       E -> K (in dbSNP:rs11570019).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020933.
FT   CONFLICT    575    575       S -> D (in Ref. 2; AAB21139).
FT                                {ECO:0000305}.
FT   STRAND      396    399       {ECO:0000244|PDB:4WH9}.
FT   HELIX       417    424       {ECO:0000244|PDB:4WH9}.
FT   TURN        425    431       {ECO:0000244|PDB:4WH9}.
FT   STRAND      432    439       {ECO:0000244|PDB:4WH9}.
FT   HELIX       443    447       {ECO:0000244|PDB:4WH9}.
FT   HELIX       460    468       {ECO:0000244|PDB:4WH9}.
FT   TURN        469    471       {ECO:0000244|PDB:4WH9}.
FT   STRAND      479    486       {ECO:0000244|PDB:4WH9}.
FT   STRAND      488    492       {ECO:0000244|PDB:4WH9}.
FT   HELIX       493    508       {ECO:0000244|PDB:4WH9}.
FT   STRAND      519    522       {ECO:0000244|PDB:4WH9}.
FT   HELIX       525    532       {ECO:0000244|PDB:4WH9}.
FT   HELIX       534    536       {ECO:0000244|PDB:4WH9}.
FT   STRAND      537    540       {ECO:0000244|PDB:4WH9}.
FT   HELIX       548    550       {ECO:0000244|PDB:2A2K}.
FT   HELIX       551    558       {ECO:0000244|PDB:4WH9}.
SQ   SEQUENCE   580 AA;  64987 MW;  EDE24B0E84AC1BE3 CRC64;
     MEVPQPEPAP GSALSPAGVC GGAQRPGHLP GLLLGSHGLL GSPVRAAASS PVTTLTQTMH
     DLAGLGSETP KSQVGTLLFR SRSRLTHLSL SRRASESSLS SESSESSDAG LCMDSPSPMD
     PHMAEQTFEQ AIQAASRIIR NEQFAIRRFQ SMPVRLLGHS PVLRNITNSQ APDGRRKSEA
     GSGAASSSGE DKENDGFVFK MPWKPTHPSS THALAEWASR REAFAQRPSS APDLMCLSPD
     RKMEVEELSP LALGRFSLTP AEGDTEEDDG FVDILESDLK DDDAVPPGME SLISAPLVKT
     LEKEEEKDLV MYSKCQRLFR SPSMPCSVIR PILKRLERPQ DRDTPVQNKR RRSVTPPEEQ
     QEAEEPKARV LRSKSLCHDE IENLLDSDHR ELIGDYSKAF LLQTVDGKHQ DLKYISPETM
     VALLTGKFSN IVDKFVIVDC RYPYEYEGGH IKTAVNLPLE RDAESFLLKS PIAPCSLDKR
     VILIFHCEFS SERGPRMCRF IRERDRAVND YPSLYYPEMY ILKGGYKEFF PQHPNFCEPQ
     DYRPMNHEAF KDELKTFRLK TRSWAGERSR RELCSRLQDQ
//
